How to use Technology Searches

Summary

Takeda is seeking early stage therapeutic targets, drug candidates and discovery technologies

Organization name

Takeda Research Investment

Profile

Takeda Research Investment Inc (TRI) is the corporate venture arm of Takeda Pharmaceutical Company Ltd.

They are seeking to license or invest in early stage opportunities that coincide with their core therapeutic areas:

  • cancer (solid tumors)
  • metabolic disorders (obesity, diabetes, and dyslipidemias)
  • cardiovascular disorders
  • central nervous system diseases

URL

http://www.tri-takeda.com


Your feedback

back

Search


Sector
Technology
Development Stage
Disease Category
Organ

latest entries